A multifunctional alanine-rich anti-inflammatory peptide BCP61 showed potent inhibitory effects by inhibiting both

Yun Hee Choi1, Yoon Seok Choi1, Young Kyun Kim1

  • 1Department of Pharmacy, College of Pharmacy, Chosun University, Gwangju, 501-759, Korea.

Inflammation
|February 20, 2017
PubMed

Insights

BCP61, an antimicrobial peptide, demonstrates significant anti-inflammatory effects by inhibiting key inflammatory pathways and mediators. This suggests BCP61

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • BCP61 is a unique low-molecular-weight antimicrobial peptide.
  • Its N-terminal sequence is rich in alanine and non-identical.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of BCP61.
  • To examine BCP61's impact on inflammatory mediators and signaling pathways in LPS-stimulated Raw 264.7 cells.

Main Methods:

  • Treatment of Raw 264.7 cells with varying concentrations of BCP61 (10, 50, 100 μg/mL).
  • Assessment of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), pro-inflammatory cytokines (TNF-α, IL-6), NF-κB, and MAPKs (ERK, JNK, p38) expression and production.
  • Evaluation of IκBα phosphorylation and degradation, and p65 nuclear translocation.

Main Results:

  • BCP61 inhibited LPS-induced NF-κB and MAPK signaling pathways.
  • BCP61 reduced the production of pro-inflammatory mediators including nitric oxide (NO) and prostaglandin E2 (PGE2).
  • BCP61 prevented IκBα phosphorylation and degradation, inhibiting p65 nuclear translocation.

Conclusions:

  • BCP61 exhibits potent anti-inflammatory properties.
  • BCP61 may serve as a therapeutic candidate for treating inflammation and microbial infections.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
672